More News

31 Oct 2018 Strongbridge Biopharma plc Enters into Agreement for Novo Nordisk to Acquire the U.S. and Canadian Rights to MACRILEN™ (macimorelin)
31 Oct 2018 Ophthotech Expands Gene Therapy Pipeline in Orphan Retinal Diseases with Exclusive Option for Novel Product Candidates to Treat Best Vitelliform Macular Dystrophy (Best Disease)
31 Oct 2018 Halozyme Licenses New ENHANZE® Targets For $25 Million Upfront Payment, Future Milestones And Royalties
30 Oct 2018 NEC and Transgene announce a collaboration in the field of individualized cancer immunotherapy, leveraging NEC’s AI and Transgene’s myvac™ platform
30 Oct 2018 Oblato acquires all rights to glioblastoma drug from OMRF
30 Oct 2018 ProQR receives exclusive worldwide license for IONIS-RHO-2.5Rx, now QR-1123, for autosomal dominant retinitis pigmentosa (adRP), a rare inherited form of blindness with no approved therapy
30 Oct 2018 Rigel Pharmaceuticals Enters Collaboration and License Agreement with Kissei Pharmaceutical Co., Ltd. to Develop and Commercialize TAVALISSE™ (fostamatinib disodium hexahydrate) in Japan and other Asian Countries
30 Oct 2018 Lilly and Dicerna Announce RNAi Licensing and Research Collaboration
26 Oct 2018 AbbVie to Assume Full Development and Commercial Control of Cystic Fibrosis Research Program
26 Oct 2018 Alexion and Dicerna Announce Collaboration to Discover and Develop RNAi Therapies for Complement-Mediated Diseases
24 Oct 2018 Bain Capital and Pfizer Create Cerevel Therapeutics, New CNS Company
24 Oct 2018 Zymeworks and LEO Pharma Enter into Bispecific Antibody Licensing and Research Collaboration
24 Oct 2018 IDEAYA Licenses Phase 1 Compound LXS196 For The Treatment Of Cancers With GNAQ And GNA11 Mutations
23 Oct 2018 Neos Therapeutics Licenses Pipeline Candidate for Treatment of Sialorrhea (Excessive Drooling)
23 Oct 2018 Enterome Signs Global Licensing, Co-development and Co-promotion Agreement with Takeda for the Treatment of Crohn's Disease
23 Oct 2018 REGENXBIO Announces Exclusive Worldwide License with Ultragenyx for the Treatment of CDKL5 Deficiency Disorder Using NAV Vectors
23 Oct 2018 AstraZeneca strengthens and expands oncology development and commercialisation collaboration with Innate Pharma
22 Oct 2018 Anaeropharma Science Signs Collaborative Research Agreement with Chugai on Creation of Novel Oncology Drugs Using Bifidobacterium
19 Oct 2018 GeNeuro Confirms Potential of Novel pHERV-K Antibodies for ALS in Collaboration with NINDS, Secures Rights
19 Oct 2018 Idera Pharmaceuticals Presents Data from the ILLUMINATE-204 Trial of the Combination of Tilsotolimod and Ipilimumab for Unresectable or Metastatic Melanoma Following Failure of PD-1 Inhibitor Treatment at the 2018 European Society for Medical Oncology (E
19 Oct 2018 AELIX Therapeutics and Gilead Sciences Enter into a Clinical Research Collaboration Agreement to Evaluate a Therapeutic Vaccine and TLR7 Agonist Regimen for HIV Cure
19 Oct 2018 The Parker Institute for Cancer Immunotherapy Partners with Xyphos Biosciences to Develop Universal Programmable CAR-T Cells for Cancer Treatment
18 Oct 2018 AbbVie and Morphic Therapeutic Announce Collaboration Targeting Fibrotic Diseases
18 Oct 2018 GEn1E Lifesciences Granted Exclusive Option to License University of Maryland, Baltimore’s Selective P38 Kinase Inhibitor
18 Oct 2018 Novartis announces planned acquisition of Endocyte to expand expertise in radiopharmaceuticals and build on commitment to transformational therapeutic platforms

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up
Top